Tristel (LSE:TSTL) FCF Margin % : 23.28% (As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is Tristel FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Tristel's Free Cash Flow for the six months ended in Dec. 2023 was £4.88 Mil. Tristel's Revenue for the six months ended in Dec. 2023 was £20.94 Mil. Therefore, Tristel's FCF Margin % for the quarter that ended in Dec. 2023 was 23.28%.

As of today, Tristel's current FCF Yield % is 3.66%.

The historical rank and industry rank for Tristel's FCF Margin % or its related term are showing as below:

LSE:TSTL' s FCF Margin % Range Over the Past 10 Years
Min: 10.1 Med: 15.76 Max: 21.31
Current: 19.51

During the past 13 years, the highest FCF Margin % of Tristel was 21.31%. The lowest was 10.10%. And the median was 15.76%.

LSE:TSTL's FCF Margin % is ranked better than
92.25% of 826 companies
in the Medical Devices & Instruments industry
Industry Median: -7.09 vs LSE:TSTL: 19.51

Tristel FCF Margin % Historical Data

The historical data trend for Tristel's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tristel FCF Margin % Chart

Tristel Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

FCF Margin %

Get a 7-Day Free Trial

15.82

14.55

15.84

13.98

16.85

Tristel Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial															18.24	9.94	18.54	15.26	23.28

Competitive Comparison of Tristel's FCF Margin %

For the Medical Instruments & Supplies subindustry, Tristel's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tristel's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Tristel's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Tristel's FCF Margin % falls into.

Tristel FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Tristel's FCF Margin for the fiscal year that ended in Jun. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Jun. 2023 )	/	Revenue (A: Jun. 2023 )
	=	6.067	/	36.009
	=	16.85 %

Tristel's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	4.875	/	20.943
	=	23.28 %

Tristel FCF Margin % Related Terms

Thank you for viewing the detailed overview of Tristel's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Tristel (LSE:TSTL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tristel PLC (LSE:TSTL) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

R1V:Germany

Address

Fordham Road, Unit 1B, Lynx Business Park, Newmarket, Snailwell, Cambridgeshire, GBR, CB8 7NY

Website

https://tristelgroup.com

Tristel PLC is a player in the healthcare platform. The company is a manufacturer of chlorine dioxide chemistry used for the decontamination of medical devices. Its operating segments include three sectors, Hospital medical device decontamination products which are used predominantly for infection control in hospitals; manufacture and sale of hospital environmental surface disinfection products; and pharmaceutical and personal care product manufacturing industries, veterinary and animal welfare. The company generates majority of revenue from Hospital medical device decontamination.

Tristel (LSE:TSTL) Headlines

No Headlines